The FDA’s decision to outlaw Red No. 3 serves the public good by eradicating a poisonous food colourant, which the study established causes cancer. ...
This approval is a step forward in unraveling the issues surrounding cost and availability of ameliorative measures in diabetes. ...
The FDA is now stepping up its campaign aimed at promoting public health through apprehension of unauthorised and counterfeit weight reduction products. ...
The FDA streams that oral phenylephrine should not be included in cold medications that are tagged for countertop salesbecause it is not effective, this called for responses from the industry. ...
United States – On Monday, BioNTech (22UAy. DE) said the U. S. Food and Drugs Administration, or the FDA, has cleared a partial clinical hold on a phase one trial of its still unapproved cancer treatment. The company has now ...
FDA's recalling of the highly regarded HeartMate II and III devices points at what many experts perceived as safety concerns, stressing the inevitable role of these devices as an aid in serious heart failure cases. ...
European and U.S. drug regulators confirm no increased suicide risk associated with popular diabetes and weight loss drugs containing semaglutide or its analogs. ...
The study's conclusions have highlighted the importance of implementing improvements for transparency, education of the patient and regulatory oversight to optimize FDA's accelerated drug approval program pertaining to cancer treatments. ...